An Intervention Study to Improve Therapeutic Compliance in Adult Patients With Eosinophilic Esophagitis.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

About this trial

In many chronic conditions adherence to long-term treatment is a challenge, also for patients with eosinophilic esophagitis. Interventions, such as behavioral, educational and reminder interventions might improve treatment adherence. With this trial the investigators want to assess the effects of additional education in combination with more frequent follow up and patient reminders on adherence to treatment in adult patients with eosinophilic esophagitis.

Eligibility criteria

Qualifiers

Written informed consent

Male or female patient

Age >18 years

Previous diagnosis of EoE, confirmed by histopathology, with the presence of >15 eosinophilic granulocytes per high power field (hpf) in esophageal biopsies

Disqualifiers

Severe and clinically unstable concomitant disease that may interfere with the subject's ability to participate in the study

Receive investigational treatment during the study

Dilation of esophagus required

Insufficient Dutch or English language skills to understand patient information leaflets

Trial design

Treatments tested in this trial

  • Intervention

Treatment groups

72 Participants
are divided into 2 treatment groups